Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
CURE spoke with Dr. Kathie-Ann Joseph about developments in breast most cancers care and the significance of customized, multidisciplinary remedies.Joseph was lately...
Iovance Biotherapeutics introduced information demonstrating that sufferers with superior melanoma skilled excessive response charges when handled with business Amtagvi (lifileucel) in a...
